亚太地区正气道压力 (PAP) 设备市场报告(2021-2031 年)范围、细分、动态和竞争分析

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2031

  • 产品类型 (自动气道正压通气装置, 持续气道正压通气装置, 双水平气道正压通气装置)
  • 应用 (慢性阻塞性肺病, 阻塞性睡眠呼吸暂停, 呼吸窘迫)
  • 最终用户 (医院, 门诊手术中心, 家庭护理, 康复中心)


No. of Pages: 140    |    Report Code: BMIRE00032123    |    Category: Life Sciences

Explore in Your Language
Asia Pacific Positive Airway Pressure (PAP) Devices Market
亚太地区正气道压 (PAP) 设备市场规模预计将从 2023 年的 13.4104 亿美元增至 2031 年的 23.943 亿美元。预计该市场在 2023 年至 2031 年期间的复合年增长率为 7.5%。

执行摘要和亚太地区正气道压 (PAP) 设备市场分析:

亚太地区 PAP 设备市场分为中国、日本、印度、澳大利亚、韩国和亚太其他地区。该地区市场的增长归因于人口老龄化加剧、阻塞性睡眠呼吸暂停患者人数增加、PAP 设备的技术进步、慢性阻塞性肺病 (COPD) 患病率上升以及护理从医院到家庭护理的转变。

亚太地区气道正压通气 (PAP) 设备市场细分分析:

有助于得出亚太地区气道正压通气 (PAP) 设备市场分析的关键细分是产品类型、应用和最终用户。

根据产品类型,亚太地区气道正压通气 (PAP) 设备市场分为自动气道正压通气 (APAP) 设备、持续气道正压通气 (CPAP) 设备和双水平气道正压通气 (BiPAP) 设备。持续气道正压通气 (CPAP) 设备在 2023 年占据了最大的市场份额。根据应用,亚太地区气道正压通气 (PAP) 设备市场分为慢性阻塞性肺病 (COPD)、阻塞性睡眠呼吸暂停和呼吸窘迫。 2023年,阻塞性睡眠呼吸暂停占据了最大的市场份额。根据最终用户,亚太地区气道正压通气 (PAP) 设备市场细分为医院、门诊手术中心、家庭护理和康复中心。2023年,医院占据了最大的市场份额。亚太地区气道正压通气 (PAP) 设备市场展望

与临床环境相比,患者大多更喜欢在方便舒适的家中接受治疗。PAP 设备在家庭护理环境中效果良好,可以治疗睡眠呼吸暂停和其他呼吸系统疾病,从而减轻医疗机构的负担并促进 PAP 设备的持续使用。睡眠呼吸暂停和许多其他呼吸系统疾病需要长期治疗。通过提供长期的家用解决方案,PAP 设备提高了成本效益。

向家庭医疗保健的转变直接推动了家用 PAP 设备的销售。因此,制造商专注于为这个不断扩大的市场生产用户友好、便携且高效的设备。例如,ResMed 生产了用于家庭护理的 AirMini 便携式 CPAP。它通过推动创新、创造家用设备需求以及改善发达国家和发展中国家获得呼吸护理的途径来影响市场。随着医疗保健系统越来越优先考虑家庭治疗方案,预计这种倾向将持续下去。

亚太地区正气道压力 (PAP) 设备市场国家洞察

按国家/地区划分,亚太地区正气道压力 (PAP) 设备市场包括中国、日本、印度、澳大利亚、韩国和亚太其他地区。中国在 2023 年占据最大份额。

预计中国将成为亚太地区最大的 PAP 设备市场。中国市场的增长归因于新产品获批数量的增加、老年人口患睡眠呼吸暂停的可能性不断增加以及呼吸系统疾病的患病率不断上升。中国是亚太地区发展最快的经济体之一,GDP 达 18 万亿美元,占全球经济的 18%,医疗支出占 GDP 的 7.1%。根据《中国宏观经济杂志 2021》的数据,中国 60 岁以上人口约 2.64 亿,占总人口的 18.7%。大量老年人口的存在增加了呼吸系统疾病的负担。根据 Frontier Media 2022 年 6 月发布的报告,最近的中国全国慢性阻塞性肺病 (COPD) 调查显示,中国占全球所有 COPD 病例的约 25%。与 10 年前的调查结果相比,40 岁及以上人群的 COPD 患病率增加了 67%,已达到流行病的程度。此外,哮喘估计是该国面临的一项重大公共卫生挑战。根据美国国家医学图书馆的数据,2019 年该国哮喘的患病率为 4.2%,涉及 4570 万人,这进一步增加了对 PAP 设备的需求。

公司简介

市场上的一些主要参与者包括 ICU Medical Inc;React Health(前身为 3B Medical, Inc);Fisher & Paykel Healthcare Corp Ltd;BPL Medical Technologies Pvt Ltd;Koninklijke Philips NV;Dragerwerk AG & Co KGaA;ResMed Inc;Vyaire Medical Inc;Wellell Inc;Armstrong Medical Ltd;Löwenstein Medical UK Ltd.;BMC Medical Co Ltd;和 Narang Medical Limited。等等。这些参与者正在采用扩张、产品创新和并购等各种策略,为消费者提供创新产品并增加市场份额。

亚太地区正压通气(PAP)设备市场研究方法:

本报告中的数据收集和分析采用以下方法:

二手资料研究 研究过程始于全面的二手资料研究,利用内部和外部来源收集每个市场的定性和定量数据。通常引用的二手资料研究来源包括但不限于:

公司网站、年度报告、财务报表、经纪商分析和投资者介绍。行业贸易期刊和其他相关出版物。政府文件、统计数据库和市场报告。针对在市场中运营的公司的新闻文章、新闻稿和网络广播。注意:“公司简介”部分包含的所有财务数据均已标准化为美元。对于以其他货币报告的公司,数据已使用相应年份的相关汇率转换为美元。

一手资料研究 Insight Partners 每年都会与行业利益相关者和专家进行大量一手资料访谈,以验证其数据分析并获得宝贵的见解。这些研究访谈旨在:

验证并完善二手资料研究的结果。提升分析团队的专业知识和市场理解。深入了解市场规模、趋势、增长模式、竞争动态和未来前景。一手资料研究通过电子邮件互动和电话访谈进行,涵盖不同地区的各种市场、类别、细分市场和子细分市场。参与者通常包括:

行业利益相关者:副总裁、业务发展经理、市场情报经理和全国销售经理;外部专家:估值专家、研究分析师和具有行业专业知识的关键意见领袖。

Asia Pacific Positive Airway Pressure (PAP) Devices Strategic Insights

Strategic insights for Asia Pacific Positive Airway Pressure (PAP) Devices involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-positive-airway-pressure-pap-devices-market-strategic-framework.webp
Get more information on this report

Asia Pacific Positive Airway Pressure (PAP) Devices Report Scope

Report Attribute Details
Market size in 2023 US$ 1,341.04 Million
Market Size by 2031 US$ 2,394.30 Million
Global CAGR (2023 - 2031) 7.5%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By 产品类型
  • 自动气道正压通气装置
  • 持续气道正压通气装置
  • 双水平气道正压通气装置
By 应用
  • 慢性阻塞性肺病
  • 阻塞性睡眠呼吸暂停
  • 呼吸窘迫
By 最终用户
  • 医院
  • 门诊手术中心
  • 家庭护理
  • 康复中心
Regions and Countries Covered 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳大利亚
  • 韩国
  • 亚太其他地区
Market leaders and key company profiles
  • ICU Medical Inc
  • React Health (Formely 3B Medical, Inc)
  • Fisher & Paykel Healthcare Corp Ltd
  • BPL Medical Technologies Pvt Ltd
  • Koninklijke Philips NV
  • Dragerwerk AG & Co KGaA
  • ResMed Inc
  • Vyaire Medical Inc
  • Wellell Inc
  • Armstrong Medical Ltd
  • Get more information on this report

    Asia Pacific Positive Airway Pressure (PAP) Devices Regional Insights

    The regional scope of Asia Pacific Positive Airway Pressure (PAP) Devices refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-positive-airway-pressure-pap-devices-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Positive Airway Pressure (PAP) Devices Market

    • ICU Medical Inc
    • React Health (Formerly 3B Medical, Inc)
    • Fisher & Paykel Healthcare Corp Ltd
    • BPL Medical Technologies Pvt Ltd
    • Koninklijke Philips NV
    • Dragerwerk AG & Co KGaA
    • ResMed Inc
    • Vyaire Medical Inc
    • Wellell Inc
    • Armstrong Medical Ltd
    • Löwenstein Medical UK Ltd.
    • BMC Medical Co Ltd
    • Narang Medical Limited.
    Frequently Asked Questions
    How big is the Asia Pacific Positive Airway Pressure (PAP) Devices Market?

    The Asia Pacific Positive Airway Pressure (PAP) Devices Market is valued at US$ 1,341.04 Million in 2023, it is projected to reach US$ 2,394.30 Million by 2031.

    What is the CAGR for Asia Pacific Positive Airway Pressure (PAP) Devices Market by (2023 - 2031)?

    As per our report Asia Pacific Positive Airway Pressure (PAP) Devices Market, the market size is valued at US$ 1,341.04 Million in 2023, projecting it to reach US$ 2,394.30 Million by 2031. This translates to a CAGR of approximately 7.5% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Positive Airway Pressure (PAP) Devices Market report typically cover these key segments-

  • 产品类型 (自动气道正压通气装置, 持续气道正压通气装置, 双水平气道正压通气装置)
  • 应用 (慢性阻塞性肺病, 阻塞性睡眠呼吸暂停, 呼吸窘迫)
  • 最终用户 (医院, 门诊手术中心, 家庭护理, 康复中心)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Positive Airway Pressure (PAP) Devices Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Positive Airway Pressure (PAP) Devices Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2031
  • Who are the major players in Asia Pacific Positive Airway Pressure (PAP) Devices Market?

    The Asia Pacific Positive Airway Pressure (PAP) Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • ICU Medical Inc
  • React Health (Formely 3B Medical, Inc)
  • Fisher & Paykel Healthcare Corp Ltd
  • BPL Medical Technologies Pvt Ltd
  • Koninklijke Philips NV
  • Dragerwerk AG & Co KGaA
  • ResMed Inc
  • Vyaire Medical Inc
  • Wellell Inc
  • Armstrong Medical Ltd
  • L?wenstein Medical UK Ltd.
  • BMC Medical Co Ltd
  • Narang Medical Limited.
  • Who should buy this report?

    The Asia Pacific Positive Airway Pressure (PAP) Devices Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Positive Airway Pressure (PAP) Devices Market value chain can benefit from the information contained in a comprehensive market report.